ResearcherSoochow UniversityActive in the last 2 years

Xiaoren Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4784-3876; OpenAlex author ID A5049523146. Sources: OpenAlex.

Their work

Papers: 5 (first author 3, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 5

Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer. First author DOI 10.1038/s41419-026-08766-2 ↗
Identification of PRRG1 as a possible molecular target of pancreatic cancer. First author DOI 10.1038/s41419-026-08832-9 ↗
Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. Co-author DOI 10.1038/s41419-024-07079-6 ↗
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. First author DOI 10.1038/s41419-023-05684-5 ↗
Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Co-author DOI 10.1038/s41419-021-04201-w ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Min‐Bin Chen · 4 shared papers, 2021–2026 · strength 1.02
Qian-Hui Gu · 3 shared papers, 2024–2026 · strength 0.89
Liu Y · 2 shared papers, 2026 · strength 0.67
- Paper Identification of PRRG1 as a possible molecular target of pancreatic cancer. DOI 10.1038/s41419-026-08832-9 ↗
- Paper Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-026-08766-2 ↗
Jian-Zhuo Jiang · 2 shared papers, 2024–2026 · strength 0.51
- Paper Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-026-08766-2 ↗
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Zhen-yu Ye · 2 shared papers, 2023–2026 · strength 0.48
- Paper Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-026-08766-2 ↗
- Paper Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-023-05684-5 ↗
Jia-Jie Chen · 1 shared paper, 2026 · strength 0.39
- Paper Identification of PRRG1 as a possible molecular target of pancreatic cancer. DOI 10.1038/s41419-026-08832-9 ↗
Yuan-yuan Liu · 2 shared papers, 2021–2024 · strength 0.38
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
- Paper Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. DOI 10.1038/s41419-021-04201-w ↗
Shi-qing Peng · 2 shared papers, 2021–2023 · strength 0.35
- Paper Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-023-05684-5 ↗
- Paper Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. DOI 10.1038/s41419-021-04201-w ↗
Zhenyu Ye · 1 shared paper, 2024 · strength 0.23
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Yifan Zhang · 1 shared paper, 2023 · strength 0.20
- Paper Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-023-05684-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.